These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10636480)

  • 1. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9.
    Sporer B; Koedel U; Paul R; Kohleisen B; Erfle V; Fontana A; Pfister HW
    J Neuroimmunol; 2000 Jan; 102(2):125-30. PubMed ID: 10636480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.
    Paul R; Lorenzl S; Koedel U; Sporer B; Vogel U; Frosch M; Pfister HW
    Ann Neurol; 1998 Oct; 44(4):592-600. PubMed ID: 9778257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation.
    Bourlier V; Zakaroff-Girard A; De Barros S; Pizzacalla C; de Saint Front VD; Lafontan M; Bouloumié A; Galitzky J
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1272-9. PubMed ID: 15537822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system.
    Koedel U; Kohleisen B; Sporer B; Lahrtz F; Ovod V; Fontana A; Erfle V; Pfister HW
    J Immunol; 1999 Aug; 163(3):1237-45. PubMed ID: 10415019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window.
    Rosenberg GA; Estrada EY; Dencoff JE; Stetler-Stevenson WG
    Brain Res; 1995 Dec; 703(1-2):151-5. PubMed ID: 8719627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
    Eur J Neurosci; 2011 Dec; 34(12):2015-23. PubMed ID: 22092673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition.
    Alluri H; Wilson RL; Anasooya Shaji C; Wiggins-Dohlvik K; Patel S; Liu Y; Peng X; Beeram MR; Davis ML; Huang JH; Tharakan B
    PLoS One; 2016; 11(5):e0154427. PubMed ID: 27152411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tumor necrosis factor-alpha and matrix metalloproteinase-9 in blood-brain barrier disruption after peripheral thermal injury in rats.
    Reyes R; Guo M; Swann K; Shetgeri SU; Sprague SM; Jimenez DF; Barone CM; Ding Y
    J Neurosurg; 2009 Jun; 110(6):1218-26. PubMed ID: 19199470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents.
    Rosenberg GA; Estrada EY; Mobashery S
    Brain Res; 2007 Feb; 1133(1):186-92. PubMed ID: 17184743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity.
    Campbell EM; Nunez R; Hope TJ
    J Virol; 2004 Jun; 78(11):5745-55. PubMed ID: 15140972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the role of human immunodeficiency virus type 1 Nef protein as a growth inhibitor to CD4+ T lymphocytes and for the blocking of the Nef function by anti-Nef antibodies.
    Fujii Y; Ito M; Ikuta K
    Vaccine; 1993; 11(8):837-47. PubMed ID: 8102828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat.
    Candelario-Jalil E; Taheri S; Yang Y; Sood R; Grossetete M; Estrada EY; Fiebich BL; Rosenberg GA
    J Pharmacol Exp Ther; 2007 Nov; 323(2):488-98. PubMed ID: 17704356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of p21-activated kinase 2 by human immunodeficiency virus type 1 Nef induces merlin phosphorylation.
    Wei BL; Arora VK; Raney A; Kuo LS; Xiao GH; O'Neill E; Testa JR; Foster JL; Garcia JV
    J Virol; 2005 Dec; 79(23):14976-80. PubMed ID: 16282498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat.
    Keck T; Balcom JH; Fernández-del Castillo C; Antoniu BA; Warshaw AL
    Gastroenterology; 2002 Jan; 122(1):188-201. PubMed ID: 11781293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of interleukin-15 production by HIV-1 nef protein: a role in the proliferation of uninfected cells.
    Quaranta MG; Camponeschi B; Straface E; Malorni W; Viora M
    Exp Cell Res; 1999 Jul; 250(1):112-21. PubMed ID: 10388525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of a herbimycin A-sensitive protein tyrosine kinase in extracellular action of HIV-1 Nef.
    Haraguchi S; Brigino-Buenaventura EN; Hitchcock R; James-Yarish M; Good RA; Day NK
    Immunol Lett; 2001 Jan; 75(2):97-101. PubMed ID: 11137132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines.
    Maitra RK; Ahmad N; Holland SM; Venkatesan S
    Virology; 1991 Jun; 182(2):522-33. PubMed ID: 2024488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis.
    Stoddart CA; Geleziunas R; Ferrell S; Linquist-Stepps V; Moreno ME; Bare C; Xu W; Yonemoto W; Bresnahan PA; McCune JM; Greene WC
    J Virol; 2003 Feb; 77(3):2124-33. PubMed ID: 12525647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.